US 8,415,363 B2
CRYSTALLINE FORMS OF 4-METHYL-N-[3-(4-METHYL-IMIDAZOL-1-YL)-5-TRIFLUOROMETHYL-PHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-BENZAMIDE
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 8,415,363 B2
CRYSTALLINE FORMS OF 4-METHYL-N-[3-(4-METHYL-IMIDAZOL-1-YL)-5-TRIFLUOROMETHYL-PHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-BENZAMIDE
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Paul V. Ward
Art Unit:
1624 Organic Chemistry
Agent:
Stephen Johnson
Inventors:
Paul W. MANLEY; Wen-Chung SHIEH; Paul Allen SUTTON; Piotr H. KARPINSKI; Raeann WU; Stéphanie MONNIER; Jörg BROZIO
Assignee:
--
Priority:
07/18/06
Filed:
08/03/12
Granted:
04/09/13
Expiration:
07/20/25
Abstract
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide free base and salts thereof are prepared by various processes.
Cooperative Patent Classification (CPC)
C07C07D401/14C07DA61P43/00A61P

Analytics

Cases

Patent Assignments

Citations